Targeted Therapies in Epithelial Ovarian Cancer
Joint Authors
Herzog, Thomas J.
Wright, Jason D.
Barrena Medel, Nicanor I.
Source
Issue
Vol. 2010, Issue 2010 (31 Dec. 2010), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2010-01-13
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
Epithelial ovarian cancer remains a major women's health problem due to its high lethality.
Despite great efforts to develop effective prevention and early detection strategies, most patients are still diagnosed at advanced stages of disease.
This pattern of late presentation has resulted in significant challenges in terms of designing effective therapies to achieve long-term cure.
One potential promising strategy is the application of targeted therapeutics that exploit a myriad of critical pathways involved in tumorigenesis and metastasis.
This review examines three of the most provocative targeted therapies with current or future applicability in epithelial ovarian cancer.
American Psychological Association (APA)
Barrena Medel, Nicanor I.& Wright, Jason D.& Herzog, Thomas J.. 2010. Targeted Therapies in Epithelial Ovarian Cancer. Journal of Oncology،Vol. 2010, no. 2010, pp.1-9.
https://search.emarefa.net/detail/BIM-462722
Modern Language Association (MLA)
Barrena Medel, Nicanor I.…[et al.]. Targeted Therapies in Epithelial Ovarian Cancer. Journal of Oncology No. 2010 (2010), pp.1-9.
https://search.emarefa.net/detail/BIM-462722
American Medical Association (AMA)
Barrena Medel, Nicanor I.& Wright, Jason D.& Herzog, Thomas J.. Targeted Therapies in Epithelial Ovarian Cancer. Journal of Oncology. 2010. Vol. 2010, no. 2010, pp.1-9.
https://search.emarefa.net/detail/BIM-462722
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-462722